At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared against a control shot designed more specifically for older people.

After the U.S. withdrew from the World Health Organization, it wasn't clear they would participate in this WHO-led meeting to determine the recipe for the next flu vaccine.

While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.

Moderna stock jumped more than 6% after the FDA agreed to review the drugmaker's first flu shot of the season, reversing ...

The seasonal flu shot is a yearly vaccine administered to protect against the flu, or influenza. Here are the facts and side ...

Flu season is not over yet, experts warn. Is there a second wave coming? Here's how to protect yourself as influenza keeps spreading.